Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo

Dermatol Ther. 2020 Mar;33(2):e13256. doi: 10.1111/dth.13256. Epub 2020 Feb 16.

Authors

Carmen Cantisani¹, Franca Cantoresi¹, Santo Raffaele Mercuri², Iva Binic³, Masa Golubovic³, Raffaella Marino⁴, Giovanni Paolino^{1

2}

Affiliations

¹ Unit of Dermatology, Policlinico Umberto I Hospital, Sapienza Medical School University of Rome, Rome, Italy.
² Unit of Dermatology - IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Department of Internal Medicine, University of Nis, Nis, Serbia.
⁴ Department of Internal Medicine, Ferrara Medical School, Ferrara, Italy.

PMID: 32031733
DOI: 10.1111/dth.13256

No abstract available

Publication types

Letter

MeSH terms

Aminoquinolines / therapeutic use
Antineoplastic Agents* / therapeutic use
Humans
Hutchinson's Melanotic Freckle* / drug therapy
Imiquimod / therapeutic use
Lentigo* / drug therapy
Skin Neoplasms* / drug therapy
Treatment Outcome

Substances

Aminoquinolines
Antineoplastic Agents
Imiquimod